| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| albendazole | Tablet | 200mg | |
| chloroquine | Tablet | 150mg (phosphate) | |
| hydroxychloroquine | Tablet | 400mg (sulfate) or 310mg (pure) | |
| ivermectin | Tablet | 6 mg | |
| meglumine antimoniate | Injection | 300mg/ml | |
| metronidazole | Oral liquid | 125 mg (benzoate)/5 mL | |
| metronidazole | Tablet | 500 mg | |
| pirimetamine | Tablet | 25 mg | |
| primaquine | Tablet | 15 mg (as diphosphate) | |
| primaquine | Tablet | 5 mg (phosphate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amikacin | Injection | 100 mg (sulfate)/2 mL | |
| amikacin | Injection | 500 mg (sulfate)/2 mL | |
| amoxicillin | Powder for oral liquid | 250 mg (as trihydrate)/5 mL | |
| amoxicillin | Tablet | 500 mg | |
| ampicillin | Powder for injection | 500 mg (as sodium salt) in vial | |
| benzathine benzylpenicillin | Injection | 1 200 000 IU | |
| benzylpenicillin | Powder for injection | 3 g (= 5 million IU) (sodium or potassium salt) in vial | |
| benzylpenicillin | Powder for injection | 600 mg (= 1 million IU) (sodium or potassium salt) in vial | |
| cefalexin | Capsule | 500 mg | |
| cefalexin | Solid oral dosage form | 250 mg (as monohydrate) | |
| cefalotine | Powder for injection | 1g | |
| cefotaxime | Powder for injection | 1 g (as sodium salt) | |
| ceftazidime | Powder for injection | 1 g (as pentahydrate) in vial | |
| ceftriaxone | Powder for injection | 250 mg (as sodium salt) in vial | |
| ciprofloxacin | Tablet | 500mg (hydrochloride) | |
| clarithromycin | Suspension | 250 mg/5 ml | |
| clarithromycin | Tablet | 500 mg | |
| clindamycin | Injection | 600 mg | |
| clofazimine | Capsule | 50 mg | |
| dapsone | Tablet | 100 mg | |
| doxycycline | Capsule | 100 mg (as hydrochloride or hyclate) | |
| ertapenem | Powder for injection | 1g | |
| gentamicin | Injection | 40 mg (sulfate)/ml in 2-mL vial | |
| levofloxacin | Injection | 500 mg/100 mL vial | |
| meropenem | Powder for injection | 500mg | |
| metronidazole | Injection | 500 mg in 100-mL vial | |
| neomycin | Tablet | 250 mg a 350 mg | |
| oxacillin | Powder for injection | 1 g | |
| piperacillin + beta-lactamase inhibitor | Injection | 4.5 g | |
| spiramycin | Tablet | 500 mg | |
| sulfamethoxazole + trimethoprim | Oral liquid | 200 mg + 40 mg/5 mL | |
| sulfamethoxazole + trimethoprim | Tablet | 800 mg + 160 mg | |
| sulfasalazine | Tablet | 500 mg | |
| vancomycin | Injection | 500 mg (chlorohydrate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| cycloserine | Solid oral dosage form | 250 mg | |
| ethambutol | Tablet | 400mg (chlorohydrate) | |
| ethambutol + isoniazid + pyrazinamide + rifampicin | Tablet | 275 mg + 75 mg + 400 mg + 150 mg | |
| ethionamide | Tablet | 250 mg | |
| isoniazid | Oral liquid | 50 mg/5 ml | |
| isoniazid | Tablet | 100mg | |
| isoniazid | Tablet | 300mg | |
| isoniazid + pyrazinamide + rifampicin | Tablet (dispersible) | 50 mg + 150 mg + 75mg | |
| isoniazid + rifampicin | Tablet | 75 mg + 150 mg | |
| isoniazid + rifampicin | Tablet (dispersible) | 50 mg + 75 mg. | |
| pyrazinamide | Tablet | 500 mg | |
| rifampicin | Capsule | 300 mg | |
| rifampicin | Suspension | 100mg/5ml |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| abacavir (ABC) | Tablet | 300 mg | |
| abacavir + lamivudine | Tablet | 600 mg (como sulfato) + 300 mg | |
| aciclovir | Oral liquid | 200 mg/5 mL | |
| aciclovir | Powder for injection | 250 mg (as sodium salt) in vial | |
| aciclovir | Tablet | 400 mg | |
| amphotericin B | Powder for injection | 50 mg in vial | |
| anidulafungina | Powder for injection | 100mg. | |
| caspofungina | N/A | 70 mg | |
| darunavir | Tablet | 600 mg | |
| dolutegravir | Tablet | 50 mg | |
| dolutegravir | Tablet | 50 mg | |
| dolutegravir + lamivudina + tenofovir | Tablet | 50 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate – equivalent to 245 mg tenofovir disoproxil) | |
| efavirenz (EFV or EFZ) | Tablet | 600 mg | |
| efavirenz + emtricitabine + tenofovir | Tablet | 600 mg + 200 mg + 300 mg | |
| elvitegravir + cobicistat + emtricitabina + tenofovir alafenamida | Tablet (enteric-coated) | 150 mg + 150 mg + 200 mg + 10 mg. | |
| fluconazole | Capsule | 200 mg | |
| fluconazole | Injection | 2 mg/mL in vial | |
| griseofulvin | Oral liquid | 125 mg/5 ml | |
| itraconazole | Capsule | 100 mg | |
| ketoconazole | Tablet | 200 mg | |
| lamivudine (3TC) | Oral liquid | 10mg/ml | |
| lamivudine (3TC) | Tablet | 150 mg | |
| lopinavir + ritonavir (LPV/r) | Oral liquid | 80 + 20 mg/ml | |
| lopinavir + ritonavir (LPV/r) | Tablet (heat stable) | 200 mg + 50 mg | |
| nystatin | Oral liquid | 100 000 IU/ml | |
| raltegavir | Tablet | 400 mg | |
| ritonavir | Tablet (heat stable) | 100 mg | |
| sofosbuvir + velpatasvir | Tablet | 400 mg + 100 mg. | |
| tenofovir disoproxil fumarate | Tablet | 300 mg | |
| zidovudine (ZDV or AZT) | Injection | 10 mg/mL | |
| zidovudine (ZDV or AZT) | Oral liquid | 50 mg/5 mL | |
| zidovudine (ZDV or AZT) | Tablet | 300 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| nitrofurantoin | Capsule | 50mg o 100mg | |
| nitrofurantoin | Oral liquid | 25 mg/5 ml |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| dobutamine | Injection | 12.5mg (hydrochloride)/mL in 20 ml vial | |
| dopamine | Injection | 200 mg (hydrochloride) in 5-mL ampoule | |
| epinephrine (adrenaline) | Injection | 1 mg (hydrochloride)/mL | |
| norepinephrine | Injectable solution | 4mg ampolla 4mL. | |
| phenylephrine | Injection | 10 mg in 1-mL ampoule |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amiodarone | Injection | 50 mg/mL in 3-mL ampoule (hydrochloride) | |
| amiodarone | Tablet (HCI) | 200 mg (hydrochloride) | |
| carvedilol | Tablet | 12.5 mg | |
| carvedilol | Tablet | 6.25 mg | |
| digoxin | eli | 0.05 mg/ml x 60 ml | |
| digoxin | Injection | 250 micrograms/mL in 2-mL ampoule | |
| digoxin | Oral liquid | 0.75 mg/mL | |
| digoxin | Tablet | 250 mcg | |
| enalapril | Tablet | 5 mg (as hydrogen maleate) | |
| indomethacin | Injection | 1 mg (sodium salt) | |
| propranolol | Injection | 1mg (hydrochloride)/ml | |
| propranolol | Tablet | 10mg (hydrochloride) | |
| verapamil | Injection | 5 mg (hydrochloride) in 2 ml ampoule | |
| verapamil | Tablet | 80 mg (hydrochloride) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| atenolol | Tablet | 50 mg | |
| enalapril | Tablet | 20 mg (maleate) | |
| hydralazine | Powder for injection | 20 mg (hydrochloride) in ampoule | |
| hydralazine | Tablet | 10mg (chlorohydrate) | |
| hydralazine | Tablet | 50 mg (hydrochloride) | |
| hydrochlorothiazide | Oral liquid | 50 mg/5 ml | |
| hydrochlorothiazide | Tablet (scored) | 25 mg | |
| irbesartan | Tablet | 150 mg | |
| methyldopa | Tablet | 250 mg | |
| methyldopa | Tablet | 500mg | |
| propranolol | Tablet | 40 mg (hydrochloride) | |
| sodium nitroprusside | Powder for infusion | 50 mg in ampoule |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| acetazolamide | Tablet | 250 mg | |
| furosemide | Injection | 20 mg/2 mL | |
| furosemide | Tablet | 40 mg | |
| furosemide | Tablet | 5 mg. | |
| mannitol | Injectable solution | 20% | |
| spironolactone | Tablet | 100mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amlodipine | Tablet | 5 mg (besylate) | |
| glyceryl trinitrate | Solution for injection | 5 mg/ ml | |
| glyceryl trinitrate | Tablet (sublingual) | 0.5 - 0.6 mg | |
| isosorbide dinitrate | Tablet | 20 mg. | |
| nimodipine | Tablet | 30 mg. |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| acetylsalicylic acid | Tablet | 100 mg | |
| clopidogrel | Tablet | 75 mg | |
| enoxaparin | Injection | 40 mg/ 0.4 ml | |
| enoxaparin | Injection | 80 mg. | |
| heparin sodium | Injection | 1000 IU/mL in 1-mL ampoule | |
| heparin sodium | Injection | 5000 IU/mL in 1-mL ampoule | |
| streptokinase | Powder for injection | 1.5 million IU in vial | |
| tirofiban | Injection | 0.25mg/ml | |
| warfarin | Tablet | 1 mg (sodium salt) | |
| warfarin | Tablet | 5 mg (sodium salt) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| aminocaproic acid | Injection | 250mg/ml | |
| complex coagulant anti-inhibitor | Powder for injection | 500 U - 20 mL. | |
| factor IX | Dried | 500 IU | |
| factor VIIa recombinante | Powder for injection | 2 mg | |
| factor VIII concentrate | Powder for injection | 250 a 300 UI | |
| factor VIII concentrate | Powder for injection | 500 a 600 UI | |
| gelatine agents | N/A | N/A | |
| phytomenadione | Injection | 1 mg/ 0.5 mL o 1mL - VIT K1 | |
| phytomenadione | Injection | 10 mg/mL in 1-mL ampoule | |
| protamine sulfate | Injection | 10 mg/mL | |
| prothrombin complex concentrate | Injection | 500 a 600 UI |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| cholestyramine | Powder for oral administration | 4-g sachet | |
| cyanocobalamin | Injection | 1 mg/ml | |
| epoetin alpha | Injection | 2000 IU/ml in 1ml vial | |
| epoetin beta | Injection | 4000 U/ 0.3 ml | |
| ferrous fumarate | Tablet (enteric-coated) | 200 mg (equivalent 66 mg iron) | |
| folic acid | Tablet | 1 mg | |
| gemfibrozil | Tablet | 600mg | |
| iron | Injection | 50 mg (dextran complex)/mL | |
| lovastatin | Tablet | 20mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| alendronic acid | Tablet | 70mg (as alendronate sodium) | |
| diclofenac | Injection | 75 mg/3 mL | |
| ibuprofen | Tablet | 400 mg | |
| indomethacin | Solid oral dosage form | 25 mg | |
| indomethacin | Suppository | 100 mg | |
| leflunomide | Tablet | 20 mg | |
| penicillamine | Capsule | 125 mg. | |
| penicillamine | Solid oral dosage form | 250 mg | |
| sulindraco | Tablet | 200 mg. | |
| tenoxicam | Tablet (enteric-coated) | 20 mg. | |
| zoledronic acid | Injection | 4 mg in vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| allopurinol | Tablet | 100 mg | |
| allopurinol | Tablet | 300 mg | |
| colchicine | Tablet | 0.5mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| dipyrone (metamizole sodium) | Injection | 500 mg/ml | |
| ibuprofen | Suspension | 100 mg/5 mL | |
| paracetamol | Oral liquid | 100 mg/ml | |
| paracetamol | Oral liquid | 120 mg/5 mL | |
| paracetamol | Suppository | 300 mg | |
| paracetamol | Tablet | 500 mg | |
| phenazopyridine hydrochloride | Tablet (enteric-coated) | 100 mg. |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| codeine phosphate + paracetamol | Tablet | 30 mg + 500 mg. | |
| fentanyl | Injection | 50 mcg (citrate)/mL | |
| methadone | Tablet | 5mg | |
| methylphenidate | Tablet | 10 mg (hydrochloride) | |
| morphine | Injection | 10 mg (sulfate or hydrochloride) in 1-ml ampoule | |
| morphine | Tablet (prolonged release) | 30 mg (morphine sulfate) | |
| morphine sulfate | Oral solution | 20 mg/mL. | |
| morphine sulfate | Tablet | 20 mg. | |
| tramadol | Injection | 50 mg (hydrochloride)/mL | |
| tramadol | Oral liquid | 100 mg (hydrochloride)/mL (as drops) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| droperidol | Injection | 2.5mg/ml | |
| ketamine | Injection | 10 mg/ml x 20 mL | |
| propofol | Aqueous emulsion | 10 mg/mL | |
| sevoflurane | Nasal solution | 250ml | |
| thiopental | Powder for injection | 0.5 g (as sodium) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| bupivacaine | Injection | 0.5% (hydrochloride) without preservant | |
| levobupivacaine hidrocloride | Solution for injection | 0.5% - 10 mL. | |
| lidocaine | Gel | 2% | |
| lidocaine | Injection | 2% (hydrochloride) + epinephrine 1:200 000 in vial + preservant | |
| lidocaine | Injection | 2% (hydrochloride) with preservant in 20 mL vial | |
| lidocaine | Injection | 2% (without preservant) | |
| lidocaine | Solution topical | 10% (100mg/mL) | |
| lidocaine hydrochloride + chlorhexidine dihydrochloride | Gel | 2% (20 mg/g) + 0.05% (0.5 mg/g) | |
| lidocaine hydrochloride + epinefrina | Solution for injection | 2% (20 mg/mL) + 1:80.000 - 1.8 mL. | |
| mepivacaine | Dental cartridge | 3% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| atracurium | Injection | 10 mg/mL (besylate) | |
| botulinum toxin A | Injection | 100 or 200 Units in single-use vial | |
| pancuronium | Injection | 2 mg (bromuro)/mL | |
| succinylcholine chloride | Injection | 50 mg/mL x 10 mL. |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| atropine | Injection | 0.5 mg (sulphate) in 1-mL ampoule | |
| hyoscine butylbromide | Injection | 20 mg in 1-mL ampoule | |
| hyoscine butylbromide | Tablet | 10mg | |
| oxibutinine hidrochloride | Tablet | 5mg. |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| betanecol | Tablet | 10 mg. | |
| neostigmine | Injection | 0,5 mg/ml | |
| neostigmine | Tablet | 15 mg (bromide) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| aminophylline | Injection | 250 mg x 10 ml | |
| beclometasone | Inhalation (aerosol) | 100 micrograms (dipropionate) per dose (as CFC free forms) | |
| fluticasone propionate | Inhalation | 250 mcg | |
| formoterol fumarate dihydrate | Powder for inhalacion | 12 ug/dosis | |
| ipratropium bromide | Inhalation (aerosol) | 20 micrograms/metered dose | |
| ipratropium bromide | Solution | 250 mcg/ ml | |
| montelukast | Tablet | 10 mg | |
| montelukast | Tablet (chewable) | 5 mg | |
| salbutamol | Metered dose inhaler (aerosol) | 0.1 mg/dose | |
| salbutamol | Oral liquid | 2 mg/5 mL | |
| salbutamol | respirator solution for use in nebulizers | 0.5% | |
| salbutamol | Tablet | 4 mg | |
| theophylline | eli | 50 mg/ 5 mL. | |
| theophylline | Tablet | 150 mg. | |
| theophylline | Tablet (prolonged release) | 250 mg | |
| tiotropium bromide monohydrate | Solution for inhalation | 2.5 mcg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| dextromethorphan | Oral liquid | 15mg (hydrobromide)/5ml | |
| dextromethorphan | Tablet | 15 mg. |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| aprepitant | Capsule | 125 mg/2 x 80 mg | |
| chlorphenamine | Injection | 10 mg (hydrogen maleate) in 1-ml ampoule | |
| chlorphenamine | Oral liquid | 2 mg/5 ml (hydrogen maleate) | |
| chlorphenamine | Tablet | 4 mg (hydrogen maleate) | |
| dimenhydrinate | Injection | 50 mg/ ml x 5 ml | |
| dimenhydrinate | Suppository | 100 mg | |
| dimenhydrinate | Suppository | 25 mg. / 1 gr. | |
| dimenhydrinate | Tablet | 50 mg | |
| diphenhydramine | Capsule | 50 mg | |
| diphenhydramine | Syrup | 12.5 mg/ 5 ml | |
| fexofenadine hydrochloride | Tablet (enteric-coated) | 120 mg. | |
| hydroxyzine | Oral suspension | 10 mg/ 5 ml | |
| hydroxyzine | Tablet | 25 mg | |
| loratadine | Syrup | 5 mg/ 5 ml | |
| tropisetron | Solution for injection | 5 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| biperiden | Injection | 5 mg (lactate) in 1-ml ampoule | |
| biperiden | Tablet | 2 mg (hydrochloride) | |
| levodopa + benserazide | Tablet | 200 mg + 50 mg | |
| levodopa + carbidopa | Tablet | 100 mg/ 25 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| ergotamine + caffeine | Tablet | 1 mg (tartrate) + 100 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| carbamazepine | Suspension | 2% x 100 ml | |
| carbamazepine | Tablet | 200 mg | |
| clonazepam | Oral liquid | 2.5 mg/ml | |
| clonazepam | Tablet | 2mg | |
| gabapentin | Capsule | 300 mg. | |
| lamotrigine | Tablet | 100 mg | |
| lamotrigine | Tablet | 25 mg | |
| phenobarbital | Solution for injection | 50 mg/mL - ampoule 1mL | |
| phenobarbital | Tablet | 100 mg | |
| phenobarbital | Tablet | 25 mg. | |
| phenytoin | Capsule | 100 mg | |
| phenytoin | Injection | 50 mg/mL | |
| phenytoin | Suspension | 2.5% (125 mg/mL) | |
| primidone | Suspension | 250 mg/ 5mL | |
| primidone | Tablet | 250 mg | |
| valproic acid (sodium valproate) | Solution | 200 mg/ml | |
| valproic acid (sodium valproate) | Tablet | 250 mg | |
| vigabatrin | Tablet | 500 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amitriptyline | Tablet | 10 mg | |
| clomipramine | Tablet | 25 mg | |
| clomipramine | Tablet | 75mg | |
| fluoxetine | Capsule | 20 mg | |
| imipramine chlorohydrate | Solid oral dosage form | 10mg | |
| imipramine chlorohydrate | Tablet | 25mg | |
| venlafaxine | Capsule | 75 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| chlorpromazine | Injection | 25 mg (hydrochloride)/mL in 2-mL ampoule | |
| chlorpromazine | Tablet (enteric-coated) | 100 mg (hydrochloride) | |
| clozapine | Tablet | 100mg | |
| fluphenazine | Injection | 25 mg (decanoate)/mL | |
| haloperidol | Injection | 5 mg/mL in 1-mL ampoule | |
| haloperidol | Oral liquid | 0.2% | |
| haloperidol | Tablet | 5 mg | |
| levomepromazine | Tablet | 25 mg (maleate) | |
| lithium carbonate | Tablet | 300 mg | |
| olanzapine | Powder for injection | 10 mg. | |
| perphenazine | Tablet | 4 mg. | |
| risperidone | Solution | 1 mg/ml | |
| risperidone | Tablet | 1mg | |
| trifluoperazine | Tablet | 5 mg (chlorohydrate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| aluminum + magnesium hydroxide | Suspension | 4.7% a 6.1% p/p y 1.4% a 2.2% p/p, F.E.U. | |
| aluminum + magnesium hydroxide | Tablet (chewable) | 200 mg/ 200 mg | |
| aluminum hydroxide | Suspension | 5.5 a 6.7% p/p | |
| aluminum hydroxide | Tablet (chewable) | 200 a 300 mg. | |
| bismuth subsalicylate | Oral suspension | 17.5% | |
| cimetidine | Injection | 300 mg in 2-mL ampoule | |
| cimetidine | Solution | 200 mg / 5mL | |
| famotidine | Tablet | 40mg | |
| mesalazine | Suppository | 1 g | |
| mesalazine | Tablet (prolonged release) | 500 mg. | |
| metoclopramide | Injection | 10 mg (hydrochloride)/2 mL | |
| metoclopramide | Tablet | 10 mg (hydrochloride) | |
| octreotide | Powder for injection | 20 mg. | |
| octreotide | Powder for injection | 30 mg. | |
| octreotide | Solution for injection | 0.1 mg/mL - 1mL | |
| omeprazole | Capsule (delayed release) | 10 mg | |
| omeprazole | Capsule (delayed release) | 20 mg | |
| omeprazole | Powder for injection | 40 mg in vial | |
| pancreatin | Capsule | 16.000 unidades F.E.U. | |
| pancreatin | Capsule | 4000 unidades F.E.U. | |
| trientine | Capsule | 250 mg | |
| ursodeoxycholic acid | Capsule | 250 - 300 mg. | |
| ursodeoxycholic acid | Tablet | 150 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| bisacodyl | Suppository | 10 mg | |
| glycerine | Suppository | 1gr. a 1.5 gr. | |
| glycerine | Suppository | 2gr. a 2.6 gr. | |
| hydrophilic psyllium muciloid + excipients | Powder | 49.70 g + 50.30 g - 200 gr. | |
| lactulose | Oral solution | 3.3 g/5 mL. | |
| laxative | enema | 5 mL. | |
| loperamide | Capsule | 2 mg | |
| magnesium hydroxido | Oral suspension | F.E.U. 7.0% a 8.5% | |
| mineral oil | Oral oily solution | 110 - 120 ml | |
| ricin oil | Oily solution | N/A | |
| sodium biphosphate/ phos enema | Oral solution | N/A |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| dexamethasone | Injection | 4 mg (phosphate)/mL | |
| dexamethasone | Tablet | 0.5 mg | |
| fludrocortisone | Tablet | 100 mcg (acetate) | |
| hydrocortisone | Injection | 100 mg (as sodium succinate) | |
| hydrocortisone | Tablet | 20 mg | |
| hydrocortisone | Tablet | 5 mg | |
| methylprednisolone | Injection | 500 mg (sodium succinate) | |
| prednisolone | Oral solution | 15 mg/ 5 mL. | |
| prednisolone | Tablet | 1 mg. | |
| prednisolone | Tablet | 25 mg | |
| prednisolone | Tablet | 5 mg | |
| triamcinolone | Injection | 10 mg/mL in 5-mL vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| danazol | Capsule | 200 mg | |
| oximetolone | Tablet | 50 mg. | |
| testosterone | Injection | 250 mg (enanthate)/mL |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| conjugated estrogens | Tablet | 0.625 mg | |
| estradiol | Oily injection | 10 mg/mL | |
| estradiol | Tablet | 2 mg | |
| ethinylestradiol + levonorgestrel | Tablet | 30 mcg + 150 mcg | |
| etonogestrel | implant | 68 mg. | |
| intrauterine contraceptive device | N/A | N/A | |
| levonorgestrel | Intrauterine | N/A | |
| medroxyprogesterone acetate | Depot injection | 150 mg/mL in 1-mL vial | |
| medroxyprogesterone acetate | Tablet | 5 mg | |
| norgestrel + ethinylestradiol | Tablet | 0.5 mg + 0.05 mg | |
| progesterone | Capsule (softgel) | 200 mg | |
| progesterone | Solution for injection | 100 mg - 1mL | |
| progesterone | Vaginal tablet | 8% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| dinoprostone | Vaginal gel | 2 mg/ 2.5 mL | |
| methylergometrine | Injection | 0.2 mg (maleate)/ml | |
| oxytocin | Injection | 5 IU/mL | |
| salbutamol | Injection | 1 mg/ mL - 5 mL |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| bromocriptine mesylate | Tablet | 2.5 mg | |
| chorionic gonadotropin (human) | Injection | 1000 IU/mL | |
| chorionic gonadotropin (human) | Injection | 250 mcg/0.5ml | |
| clomifene | Tablet | 50 mg (citrate) | |
| desmopressin | Nasal solution | 0.1 mg (acetate)/mL | |
| goserelin | Injection | 3.6 mg | |
| leuprorelin | Injection | 3.75 mg (acetate) | |
| leuprorelin (leuprolide acetate) | Injection | 11.25 MG | |
| menotropin | Injection | 75 IU | |
| somatotropic hormone | Powder for injection | 5 mg in vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| diazoxide | Capsule | 50 mg. | |
| glibenclamide | Tablet | 5 mg | |
| gliclazide | Solid oral dosage form | 80 mg | |
| intermediate-acting insulin | Injection | 100 IU/ml in 10-ml vial | |
| metformin | Tablet | 500 mg (hydrochloride) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| levothyroxine | Tablet | 100 mcg (sodium salt) | |
| levothyroxine | Tablet | 25 mcg (sodium salt) | |
| liothyronine | Tablet | 75 mg. | |
| Lugol's solution | Oral solution | 30 mL. | |
| propylthiouracil | Tablet | 50 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| anastrozole | Tablet | 1mg | |
| asparaginase | Powder for injection | 10 000 IU in vial | |
| azathioprine | Tablet | 50 mg | |
| basiliximab | Powder for injection | 20 mg | |
| bleomycin | Injection | 15 IU | |
| capecitabine | Tablet | 500 mg | |
| carboplatin | Injection | 150 mg/15 mL | |
| carboplatin | Injection | 450 mg/45 mL | |
| chlorambucil | Tablet | 2 mg | |
| cisplatin | Powder for injection | 10 mg in vial | |
| citarabine | Injection | 100 mg | |
| citarabine | Injection | 500 mg | |
| cyclophosphamide | Powder for injection | 500 mg in vial | |
| cyclophosphamide | Tablet | 50 mg | |
| cyclosporine | Oral liquid | 100 mg/ml | |
| dacarbazine | Injection | 200 mg | |
| dactinomycin | Powder for injection | 500 mcg in vial | |
| docetaxel | Injection | 20 mg/ml | |
| docetaxel | Solution for injection | 80 mg/ 4 ml | |
| epirubicin | Injection | 50 mg/25 ml | |
| erlotinib | Tablet | 150 mg | |
| etoposide | Injection | 20 mg/mL in 5-mL ampoule | |
| exemestane | Tablet | 25 mg | |
| filgrastim | Injection | 30,000,000 IU | |
| fluorouracil | Injection | 500mg/10ml | |
| flutamide | Tablet | 250 mg | |
| gemcitabine | Injection | 1g (chlorohydrate) | |
| gemcitabine | Injection | 200mg (chlorohydrate) | |
| hydroxycarbamide | Capsule | 500 mg | |
| idarubicin | Powder for injection | 5 mg in 5 mL vial | |
| ifosfamide | Powder for injection | 1 g in vial | |
| imatinib | Tablet | 400 mg (as mesylate) | |
| interferon alpha 2B | Injection | 10 000 000 IU | |
| interferon beta 1A | Solution for injection | 22 ug (6 millones U.I/ 0.5 mL) | |
| interferon beta 1A | Solution for injection | 30 ug (6 millones U.I/ 0.5 mL) | |
| interferon beta 1A | Subcutaneous administration | 44UG/0,5ml | |
| interferon beta 1B | Powder for injection | 0.25 mg. (8.0 mill. de U.I/ mL) | |
| irinotecan | Solution for injection | 20 mg/ mL | |
| melphalan | Powder for injection | 50mg. | |
| melphalan | Tablet | 2 mg | |
| mercaptopurine | Tablet | 50 mg | |
| methotrexate | injection for intravenous administration | 50MG/2ML | |
| methotrexate | Solution for injection | 1000 mg/ 10 ml | |
| methotrexate | Tablet | 2.5 mg (as sodium salt) | |
| mitomycin | Injection | 5 mg | |
| mycophenolate mofetil | Capsule | 250 mg. | |
| oxaliplatin | Injection | 50 mg | |
| paclitaxel | Solution for injection | 6mg/mL | |
| pazopanib | Tablet | 200 MG | |
| rituximab | Injection | 100 mg | |
| rituximab | Injection | 500 mg/50 mL | |
| Sunitinib (malate) | Capsule | 50 mg. | |
| tacrolimus | Capsule | 0.5 mg | |
| tacrolimus | Capsule | 1 mg | |
| tamoxifen | Tablet | 20 mg (as citrate) | |
| temozolomide | Capsule | 100 MG | |
| temozolomide | Capsule | 20 mg | |
| thalidomide | Tablet | 100 mg | |
| trastuzumab | Solution for injection | 600 mg/ 5 ml | |
| tretinoin | Capsule | 10 mg. | |
| vinblastine | Powder for injection | 10 mg (sulfate) in vial | |
| vincristine | Injection | 1 mg/mL |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| ascorbic acid | Oral liquid | 100 mg/mL | |
| ascorbic acid | Tablet | 500 mg | |
| calcitriol | Capsule | 0.25 mcg | |
| calcitriol | Capsule (softgel) | 1 mcg. | |
| cholecalciferol | Solution (eye drops) | 10000 UI/ 1 ml - 30 ml | |
| isotretinoin | Capsule | 10 mg. | |
| multivitamins | Powder for injection | N/A | |
| multivitamins | Powder for injection | Pediatric | |
| pyridoxine | Injection | 50 mg in 1 ml ampoule (hydrochloride) | |
| pyridoxine | Tablet | 50mg (chlorohydrate) | |
| retinol | Capsule | 25 000 IU | |
| thiamine | Injection | 100mg (chlorohydrate)/ml | |
| thiamine | Tablet | 100mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amino acids | Injection | 6% | |
| amino acids | Solution for injection | 10% | |
| balanced electrolyte solution | Solution for injection | 1000 mL | |
| balanced electrolyte solution | Solution for injection | with sodium gluconate - 1000 mL | |
| calcium carbonate | Tablet | 750 mg | |
| calcium gluconate | Injection | 100 mg/mL in 10-mL ampoule | |
| dextran 40 | Intravenous administration | 10% in 500-mL bottle | |
| dextran 70 | Injectable solution | 70 6% - 500 mL. | |
| dextrose | Injectable solution | 10% - 1000 mL. | |
| dextrose | Injectable solution | 10% - 250 mL. | |
| dextrose | Solution for injection | 5% - 1000 mL. | |
| dextrose | Solution for injection | 5% - 100mL | |
| dextrose | Solution for injection | 5% - 250 mL | |
| dextrose | Solution for injection | 5% - 50 mL | |
| dextrose | Solution for injection | 5% - 500 mL. | |
| dextrose | Solution for injection | 50% - 1000 mL. | |
| dextrose | Solution for injection | 50% - 50 mL | |
| dextrose + sodium chloride + potassium chloride | Solution for injection | 5% + 0.3% + 0.149% - 250 mL. | |
| dextrose + sodium chloride + potassium chloride | Solution for injection | 5% + 0.3% + 0.149% - 500 mL. | |
| Dextrose + sodium chloride + potassium chloride + sodium acetate | Solution for injection | 1% + 0.5% + 0.1% + 0.65% - 2000 mL | |
| Dextrose + sodium chloride + potassium chloride + sodium acetate | Solution for injection | 2% + 0.35% + 0.15% + 0.4082 - 500 mL | |
| hemodialysis solution | Solution | N/A | |
| lipid emulsion | Injection | 20% | |
| magnesium sulfate | Injection | 200 mg/mL in 10-mL ampoule | |
| monobasic sodium phosphate + dibasic sodium phosphate | Injection | 224 mg + 236 mg / 15 mL. | |
| oral rehydration salts | Powder for oral administration | 6.7 gr | |
| peritoneal dialysis solution | Solution | Dextrose 1.5% - 2000 mL. | |
| peritoneal dialysis solution | Solution | Dextrose 4.25% - 2000 mL. | |
| phosphates | Sachet | 1 gr - 1.2 gr. | |
| potassium chloride | Solution | 2 mEq/ml | |
| potassium gluconate | Oral liquid | 31.2% | |
| sodium bicarbonate | Injection | 8.4% | |
| sodium chloride | Parenteral formulation | 0.9% (100 mL) | |
| sodium chloride | Solution | 0.9% 250 ml | |
| sodium chloride | Solution | 0.9% 500 ml | |
| sodium chloride | Solution for injection | 9% / 50 ml | |
| Sodium chloride + potassium chloride + magnesium chloride + calcium chloride | Solution for injection | 0.643% + 0.1193% + 0.3253% + 0.0176% - 1000 mL. | |
| sodium chloride hypertonic | Injection | 4 molar | |
| trace elements (oligoelementos) | Solution for injection | N/A | |
| trace elements (oligoelementos) | Solution for injection | Pediatrics | |
| water for injection | N/A | 10-ml ampoules |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| albumin | Injection | 20%-25% | |
| anti-D immunoglobulin (human) | Injection | 250-300 mcg/2 mL | |
| anti-hepatitis B immunoglobulin | Injection | 200 UI/ ml | |
| antitetanus immunoglobulin (human) | Injection | 250 UI | |
| BCG vaccine | Powder for injection | multidose | |
| diphtheria, tetanus toxoid | Injection | 0.5 mL | |
| diphtheria, tetanus toxoid | Solution for injection | 5 ml (multidose) | |
| diphtheria, tetanus toxoid + pertussis vaccine | Injection | N/A | |
| haemophilus influenzae type b vaccine (Hib vaccine) | Injection | 1 dose | |
| hepatitis B vaccine | Injection | pediatric | |
| hepatitis B vaccine (recombinant) | Injection | 1 ml (1 dose) | |
| human papilloma virus (HPV) vaccine | Injection | 0.5 ml (1 dose) | |
| Immunoglobulin IV | Solution for injection | 2.5 g (50 mg/mL) | |
| Immunoglobulin Varicela Zoster | Solution for injection | 125 UI/mL. | |
| influenza vaccine | Injection | 0.25 ml | |
| influenza vaccine | Injection | 0.5 ml | |
| MMR vaccine | Injection | 1 dose -preservative-free | |
| MMR vaccine | Powder for injection | unit dose - multidose | |
| MR vaccine | Injection | measles, rubella | |
| ophidic antivenom | Solution for injection | N/A | |
| ophidic antivenom | Solution for injection | anticoral - 10 mL. | |
| pneumococcal vaccine -23 | Solution for injection | 0.5 mL - 1 dose | |
| rabies vaccine | Injection | 1 dose | |
| rotavirus vaccine | Oral suspension | 1.5 mL - unica dosis. | |
| vacuna sarampion y rubeola | Powder for injection | N/A | |
| varicella vaccine | Powder for injection | N/A |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| acetylcholine | Solution (eye drops) | 20 mg/ 2 ml | |
| aciclovir | Ointment | 3% W/W | |
| atropine | Solution (eye drops) | 1% (sulfate) | |
| azul de tripano | Solution | 0.06% (0.6 mg/mL) - 0.5 mL | |
| betamethasone sodium phosphate + neomycin sulphate | Solution (eye drops) | 0.1% / 0.35% - 5mL | |
| ciprofloxacin | Topical | 0.3% drops (as hydrochloride) | |
| cyclopentolate | Solution (eye drops) | 1% (hydrochloride) | |
| dorzolamide | Solution (eye drops) | 2% (hydrochloride) | |
| fluorometholone | Solution (eye drops) | 0.1% | |
| gentamicin | Solution (eye drops) | 0.3% | |
| hyaluronate sodium | Injection | 10 mg/ 1.0 ml | |
| hyaluronidase | Injection | 150 IU | |
| hypromellose | Solution (eye drops) | 0.3% | |
| hypromellose | Solution (eye drops) | 0.3% | |
| latanoprost | Solution (eye drops) | 0.005% | |
| normal saline | Solution (eye drops) | 500 mL | |
| olopatadine hcl | Solution (eye drops) | 1% (1 mg/mL) - 5 mL | |
| oxymethazoline | Solution (eye drops) | 0.25 mg/ mL (hydrocloride) | |
| phenylephrine | Solution (eye drops) | 100 mg/ ml | |
| phenylephrine+tropicamide | Solution (eye drops) | 0.8% - 5 mL. | |
| pilocarpine | Solution (eye drops) | 2% (hydrochloride) | |
| prednisolone | Solution (eye drops) | 1% (acetate) | |
| rivoflavin + dextran | Solution | > 0.1% p/v + 500 al 20% p/v. | |
| Sodium hyaluronate + Sodium chondroitin sulfate | Injectable solution | 30 mg/mL + 40 mg/mL | |
| tetracaine | Solution (eye drops) | 0.5% (hydrochloride) | |
| tetracycline | Eye ointment | 10 mg (hydrochloride)/g | |
| timolol | Solution (eye drops) | 0.5% (maleate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| acitretin | Capsule | 25 mg. | |
| aluminum acetate | Powder | N/A | |
| antiseptic alcoholic solution | Solution | 350 mL / 500 mL. | |
| benzoyl peroxide | Gel | 5% | |
| betamethasone | Cream | 0.1% (as valerate) | |
| betamethasone | Ointment | 0.1% (as valerate) | |
| bifonazol | Cream | 1% | |
| brea concentrated | shampoo | 150 mL / 180 mL. | |
| calamine | Lotion | N/A | |
| chlorhexidine | Solution | 7.1% (digluconate) delivering 4% chlorhexidine (for umbilical cord care) | |
| coal tar | Ointment | 28 gr - 45 gr. | |
| crotamiton | Lotion | 10% | |
| fluorouracil | Cream | 5% | |
| hydrocortisone | Lotion | 0.5% (acetate) | |
| hydrocortisone | Ointment | 1% (acetate) | |
| hydrocortisone | Topical | 0.25% (acetate) | |
| hydrogen peroxide | Solution | 3% | |
| iodine-povidone | Topical forms | 7-10% (foam and solution) | |
| methoxsalen | Tablet | 10 mg | |
| mineral | oil | N/A | |
| podophyllum resin | Solution topical | 25% | |
| potassium iodide | Oral solution (drops) | 1g/mL - 30 mL | |
| rose cream | Cream | 40 g / 60 g. | |
| salicylic acid | Ointment | 5% (50 mg/g) - 40-60 g | |
| salicylic acid | Solution topical | 15% - 17% | |
| silver sulfadiazine | Cream | 1% | |
| silver sulfadiazine | Cream | 1% (50g) | |
| sodium fusidate | Ointment | 2% (20 mg/g) | |
| sulisobenzone | Lotion | 10% | |
| trioxisaleno | Tablet | 5 mg. | |
| zinc oxide | Cream | 45/50/60 gr. |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| conjugated estrogens | Tablet | 0.625 mg | |
| miconazole | Ovules | 200/400/1200 mg. (nitrate) | |
| polycresulene | Gel | 18 mg/g. - 50g. | |
| polycresulene | Ovules | 90 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| acetylcysteine | Tablet (dispersible) | 600 mg. | |
| deferasirox | Tablet | 500 mg | |
| flumazenil | Injection | 0.1 mg/ml | |
| naloxone | Injection | 0.4 mg/mL | |
| obidoxime | Injection | 250 mg (chloride)/mL |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| antihemorrhoidal preparation (corticosteroid + local anesthetic) | Ointment | 30 gr/ 60 gr. | |
| antihemorrhoidal preparation (corticosteroid + local anesthetic) | Suppository | 1 gr/ 2gr |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| 2% acetic acid in aluminum acetate solution | otic drops | 60 mL | |
| acetic acid | Topical | 2%, in alcohol | |
| benzoin tincture 20% | Solution | 60 mL | |
| oxymethazoline | Nasal spray | 0.5 mg/ml | |
| oxymethazoline | Solution (eye drops) | 0.25 mg/ mL (hydrocloride) | |
| Soften earwax (Potassium carbonate, glycerin or propylene glycol) | otic drops | 30 mL |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| 131 iodine (Na 131 I ) | Capsule | 1 mCi - 200 mCi | |
| 131 iodine (Na 131 I ) | Oral solution | 25 mCi - 200 mCi | |
| 99 mTc-Tropano | Injectable solution | N/A | |
| 99mTc sodium pertechneciate | Injection | 74 GBq - 277.5 GBq | |
| 99mTc-colloidal sulfide | Powder for injection | N/A | |
| 99mTc-mebrophenin | Powder for injection | N/A | |
| 99mTc-oxidronato | Powder for injection | N/A | |
| 99mTc-pentetate | Powder for injection | N/A | |
| 99mTc-pyrophosphate | Powder for injection | N/A | |
| barium sulfate | Powder for oral suspension | 85% P/P | |
| besilesomab marked with technetium (Tc-99m) | Powder for injection | N/A | |
| colloidal rhenium sulfide (Nanocolloid) + 99 mTc | Injectable solution | N/A | |
| effervescent granules for oral use | Oral solution | Ampoule 3 gr - 3,5 gr | |
| gadoteric acid | Solution for injection | 0.5 mol/mL - 15mL | |
| gallium Citrate (67 Ga) | Aqueous solution | 1 mCi - 3 mCi / 5mL - 10 mL | |
| gonadorelina | Powder for injection | 100 mcg | |
| Indian marked Octreotid 111 | Powder for injection | 3 to 5 mCi | |
| Iobenguano (131I) | Injectable solution | 1.25 mCi to 1.5 mCi - 5 mL | |
| iohexol | Injection | equiv 300mg iodo/ml in 50 or 100ml vial | |
| iohexol | Injection | equiv 300mg iodo/ml in 50 or 100ml vial | |
| meglumine and sodium ioxitalamate | Solution for injection | 55% (550 mg/mL) + iodine 25% - 20mL | |
| meglumine diatrizoate | Oral liquid | 66% + 10% sodium diatrizoate | |
| norcolesterol iodado (131 I) | Injectable solution | 1 mCi to 2 mCi - 2.5 mL to 10 mL | |
| protirelin | Injectable solution | 200 mcg. - 1 mL | |
| rhenium (186 Re) colloidal sulfide | Injection | 220 MBq/mL to 335 MBq/mL | |
| succimer | Powder for injection | for technetium 99mTc-succimer - ampoule | |
| Technetium 99mTc-Albumin added | Powder for injection | N/A | |
| Technetium 99mTc-bicisate | Powder for injection | N/A | |
| Technetium 99mTc-Mertiatida | Powder for injection | N/A |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| fluorescein | Injection | 10% | |
| fluorescein | Solution (eye drops) | 2% | |
| gonadorelina | Powder for injection | 100 mcg | |
| methylthioninium chloride (methylene blue) | Injection | 1% | |
| protirelin | Injectable solution | 200 mcg. - 1 mL | |
| tuberculin, purified protein derivative (PPD) | Injection | N/A |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| charcoal, activated | Powder | N/A | |
| ethyl alcohol (ethanol) | Liquid | FEU 95º | |
| ethyl alcohol (ethanol) | Liquid | FEU 95º | |
| ethyl alcohol (ethanol) | Liquid | FEU 95º | |
| ethyl alcohol (ethanol) | Liquid | FEU 95º |